Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950144-97-003910
Filing Date
1997-04-08
Accepted
1997-04-08 00:00:00
Documents
5
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 PHARMACEUTICAL PRODUCT DEVELOPMENT INC S-3 S-3 33810
2 REGISTRATION RIGHTS AGREEMENT 3/1/97 PPD/BELMONT EX-4.1 34409
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP EX-5.1 2096
4 CONSENT OF COOPERS & LYBRAND LLP EX-23.1 1162
5 CONSENT OF RTHUR ANDERSEN LLP EX-23.2 554
  Complete submission text file 0000950144-97-003910.txt   73850
Mailing Address
Business Address 3151 17TH STREET EXTENSION WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-24779 | Film No.: 97576721
SIC: 8731 Services-Commercial Physical & Biological Research